Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • Telemedicine BW
    • MDR & IVDR

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 18/03/2013 19352_de.jpg

    Identification of genes that play a crucial role in regulating cholesterol levels

    Genome-wide association studies (GWAS), which were combined with RNA interference studies and microscope-based functional analyses, enabled researchers from the European Molecular Biology Laboratory and Heidelberg University Hospital to identify genes that play key roles in the regulation of the blood cholesterol level. The new method leads to a better understanding of the relationships between the lipid metabolism and the development of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/identification-of-genes-that-play-a-crucial-role-in-regulating-cholesterol-levels
  • Article - 11/03/2013 19314_de.jpg

    Trenzyme – optimal expression of recombinant proteins

    Trenzyme GmbH in Konstanz offers services and products in the fields of genomics and proteomics. The company specialises in contract research and custom R&D services and is also working on new and improved products and processes. The company recently developed a new method for the rapid identification of optimal expression conditions for recombinant proteins.

    https://www.gesundheitsindustrie-bw.de/en/article/news/trenzyme-optimal-expression-of-recombinant-proteins
  • Article - 04/03/2013 19277_de.jpg

    Genomic structural variations can cause cancer

    Genome-wide sequencing analyses show that comprehensive structural variations of chromosomes can play a key role in the pathogenesis of many types of cancer. Dr. Jan Korbel’s research group at the European Molecular Biology Laboratory in Heidelberg has been investigating chromosomal aberrations in paediatric brain tumours and early-onset prostate cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/genomic-structural-variations-can-cause-cancer
  • Article - 25/02/2013 19245_de.jpg

    Computomics: unlocking the secrets of plant genome sequences

    Thanks to the latest generation of sequencing technology, the deciphering of the complete genome of organisms is becoming faster and cheaper. The challenge is to compile the book of life from millions of DNA fragments and unlock the secrets of the human and other organisms. The young bioinformatics company Computomics in Tübingen is doing just this for crops. In contrast to the human genome, the genome of the majority of plants is still a book…

    https://www.gesundheitsindustrie-bw.de/en/article/news/computomics-unlocking-the-secrets-of-plant-genome-sequences
  • Article - 18/02/2013 18791_de.jpg

    AIDS researchers from Ulm to shed light on the success of the HIV-1 M group

    Frank Kirchhoff AIDS researcher at the University of Ulm has come up with a plausible explanation for the pandemic spread of the human immunodeficiency virus 1 HIV-1 M group and its ability to adapt to the human immune system. In a recent study with colleagues from Germany and abroad Kirchhoff used molecular biology methods to investigate the group and compare it with the relatively rare HIV-1 N group. Kirchhoff hopes that the molecular…

    https://www.gesundheitsindustrie-bw.de/en/article/news/aids-researchers-from-ulm-to-shed-light-on-the-success-of-the-hiv-1-m-group
  • Article - 11/02/2013 19149_de.jpg

    Johannes Krause examines historical pathogens: old pathogens in a new light

    Palaeogeneticist Johannes Krause is drawn to ancient DNA. His work on the evolution of human pathogens shows that his findings are not purely of historical interest, but also enable conclusions to be made on future disease outbreaks and epidemics. In autumn 2012, Krause was awarded an ERC Starting Grant. Krause uses the grant to expand his research into plague and other historical pathogens that continue to be a threat to human health.

    https://www.gesundheitsindustrie-bw.de/en/article/news/johannes-krause-examines-historical-pathogens-old-pathogens-in-a-new-light
  • Article - 04/02/2013 19110_de.jpg

    DKFZ-HIPO – the Heidelberg Center for Personalised Oncology

    The German Cancer Research Center (DKFZ) and the National Center for Tumour Diseases (NCT) have jointly initiated the Heidelberg Center for Personalised Oncology (HIPO) which provides cancer patients with high-throughput genetic and molecular analyses. In anticipation of the upcoming World Cancer Day on 4th February 2013, the potential of high-throughput genetic and molecular analyses in improving cancer therapy was presented at a workshop held…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dkfz-hipo-the-heidelberg-center-for-personalised-oncology
  • Article - 18/12/2012 18996_de.jpg

    Gene therapy medicinal products: the first gene therapy product has been approved – where does the future lie?

    Is gene therapy close to broad clinical application? Following negative headlines at the end of the 1990s gene therapy had almost disappeared from the public radar to become an issue almost exclusively dealt with by research laboratories. Gene therapy has now reappeared in the public domain since the European Medicines Agency EMA gave the Dutch biotech company uniQure the go-ahead for the application of somatic gene therapy for the treatment of a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/gene-therapy-medicinal-products-the-first-gene-therapy-product-has-been-approved-where-does-the-futu
  • Press release - 14/12/2012 18952_de.jpg

    Need for Speed: High-speed Measurements of Molecular Motion in the Cell Nucleus

    They were able to measure the binding of highly specialised protein complexes that specifically change the spatial structure of the genetic information thereby controlling the readout of the DNA information. The work of Dr. Karsten Rippe and his team was carried out at the BioQuant Center of Heidelberg University and the German Cancer Research Center. Their research has demonstrated that the positioning of nucleosomes complexes of DNA and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/need-for-speed-high-speed-measurements-of-molecular-motion-in-the-cell-nucleus
  • Article - 10/12/2012 18834_de.jpg

    A machine learning method for the prediction of regulatory interactions

    Heidelberg bioinformaticians have developed a novel method for the automated prediction of regulatory interactions. The regulatory interaction predictor, a machine-learning based approach for predicting interactions between DNA-binding transcription factors and their target genes and obtaining important insights into the gene regulatory networks in complex cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-machine-learning-method-for-the-prediction-of-regulatory-interactions
  • Press release - 05/12/2012 Illumina HiSeq2000 sequencing device.

    Next Generation Sequencing of GATC Biotech AG accredited by German DAkkS

    Being the first in Europe, the Next Generation Sequencing Laboratories of the Constance Genome and Diagnostics Centre has been accredited according to ISO 17025 from the national accreditation body for the Federal Republic of Germany (DAkks). The independent governmental institution has acknowledged the high quality standard of the sequencing service on technology platforms Illumina HiSeq and Roche GSFLX sequencing.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/next-generation-sequencing-of-gatc-biotech-ag-accredited-by-german-dakks
  • Dossier - 26/11/2012 18780_de.jpg

    Genetic diagnostics: technology reaches the limits of what is medically reasonable

    Rapid progress in sequencing technologies is poised to set the imagination of biomedical researchers on fire. Experts now believe that progress is about to make possible what seemed to be utopian a few years ago – it seems likely that it will soon be possible to sequence the human genome in only a few minutes and store and automatically analyse it using tiny automates. However, is everything that is technically feasible also reasonable?

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/genetic-diagnostics-technology-reaches-the-limits-of-what-is-medically-reasonable
  • Press release - 22/11/2012 18767_de.jpg

    CeGaT and Genomatix are finalists of Boston Children’s Hospital’s CLARITY challenge

    CeGaT (Center for Genomics and Transcriptomics) GmbH, the Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn and Genomatix Software GmbH were announced as finalist (Top 3) of the CLARITY challenge, organized by Boston Children’s Hospital.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-and-genomatix-are-finalists-of-boston-children-s-hospital-s-clarity-challenge
  • Article - 19/11/2012 18680_de.jpg

    Uncovering the genetics of prostate cancer

    The prostate genome project, which is part of the International Cancer Genome Consortium, is focused on the genetic and epigenetic causes of the development and progression of this highly variable cancer and finding markers that enable the reliable diagnosis of the disease. The German research groups involved in the project are coordinated by the German Cancer Research Center and concentrate on prostate cancer patients under 50 years of age, as…

    https://www.gesundheitsindustrie-bw.de/en/article/news/uncovering-the-genetics-of-prostate-cancer
  • Press release - 12/11/2012 Immatics Logo

    immatics appoints Peter Chambré as Chairman

    immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced the appointment of Peter Chambré as Chairman of the Board with immediate effect. Peter Chambré has had extensive senior management experience in the biopharmaceutical sector and now holds several Chairman positions in the life sciences industry. He will replace Thomas Widmann, who has…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-appoints-peter-chambr-as-chairman
  • Press release - 12/11/2012 16634_de.jpg

    Searching for new strategies against prostate cancer

    The European Research Council (ERC) has announced that Roland Schüle, Scientific Director at the Department of Urology, University of Freiburg Medical Centre has been awarded an ERC Advanced Grant. Professor Schüle will receive €2.5 million for a period of 5 years for his research proposal to identify and characterize the molecular and physiological functions of the epigenetic enzyme LSD1 and to explore its role in prostate cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/searching-for-new-strategies-against-prostate-cancer
  • Press release - 12/11/2012 18629_de.jpg

    Spot the difference: The 1000 Genomes Project

    The 1000 Genomes Project presents a map of normal human genetic variation – everything from tiny changes in the genetic code to major alterations in our chromosomes. In a DNA version of ‘spot-the-difference’, EMBL scientists and their colleagues studied the genomes of 1092 healthy people from Europe, the Americas and East Asia, systematically tracking what makes us different from each other. Their results, published in Nature, open new approaches…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/spot-the-difference-the-1000-genomes-project
  • Press release - 12/11/2012 GATC Biotech AG Logo

    GATC Biotech joins a new EU research network for young researchers

    Seven European research institutions and GATC Biotech have formed a consortium providing cutting-edge training in the scientific study of the human past. The BEAN (Bridging the European and Anatolian Neolithic) Initial Training Network has been awarded four years of funding from the European Commission through the Marie Curie Actions program. It is a new multinational and multidisciplinary Marie Curie Research initiative exploring the origins of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-joins-a-new-eu-research-network-for-young-researchers
  • Dossier - 05/11/2012 18550_de.jpg

    Cancer – basic research, successes and trends

    Science is approaching cancer treatment by using new systems biology approaches and setting up large-scale multidisciplinary projects such as the International Cancer Genome Consortium. Progress in genome, epigenome and gene expression analyses of cancer cells, new insights into the regulation and interaction of cells gained in cooperation with stem cell research and virus research contributes to gaining a causal understanding of cancer. This…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/cancer-basic-research-successes-and-trends
  • Article - 05/11/2012 18555_de.jpg

    Biophysicist Jens Michaelis takes a look into the molecular machine room

    Jens Michaelis is extremely interested in the molecular machines that control the gene expression process. He has developed a method that enables basic researchers to localise biomolecules in real time as well as gaining insights into their spatial order. In fact what the method does is actually allow researchers to watch proteins at work.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biophysicist-jens-michaelis-takes-a-look-into-the-molecular-machine-room
  • Press release - 30/10/2012 Logo DKFZ, blue letters "DKFZ"

    DKFZ and Genetic Immunity Sign Collaboration Agreement to Develop HPV Therapeutic Vaccine

    Genetic Immunity, Budapest, a leader in immunotherapy technology product development, and DKFZ (German Cancer Research Center, Heidelberg, Germany) signed a collaborative agreement to develop a DNA-based vaccine for the treatment of Human Papilloma Virus (HPV) infection that causes cervical cancer and other cancers of the anus, penis, vulva, vagina, and oropharynx. Present HPV vaccines (Cervarix, Gardasil) have no therapeutic effect on…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dkfz-and-genetic-immunity-sign-collaboration-agreement-to-develop-hpv-therapeutic-vaccine
  • Press release - 26/10/2012 18517_de.jpg

    What causes chronic bowel disease?

    Europe-wide network for investigating irritable bowel syndrome headed by Heidelberg University HospitalEuropean Science Foundation provides 500000 euros in funding for understanding causes improving options for diagnosis and treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-causes-chronic-bowel-disease
  • Press release - 09/10/2012 European Flag

    European Commission proposes measures to tackle 'biopiracy' and facilitate nature-based research

    On 4th October 2012 researchers and companies in the EU received a boost today with a new proposal that should provide reliable access to genetic resources from outside the Union. The proposal is designed to protect the rights of countries and of indigenous and local communities that allow their genetic resources and associated traditional knowledge to be used while also giving researchers in Europe improved reliable access to quality samples of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/european-commission-proposes-measures-to-tackle-biopiracy-and-facilitate-nature-based-research
  • Article - 08/10/2012 18269_de.jpg

    The Heidelberg Institute of Human Genetics celebrates its 50th anniversary

    On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-heidelberg-institute-of-human-genetics-celebrates-its-50th-anniversary
  • Press release - 02/10/2012 11201_de.jpg

    One- or two-way transcription depends on gene loops

    In certain toy racecar tracks sneaky players can flip a switch trapping their opponents vehicles in a loop of track. Cells employ a less subtle approach they change the tracks layout. In a study scientists at the European Molecular Biology Laboratory EMBL and Oxford University discovered that by forming or undoing gene loops cells manipulate the path of the transcription machinery which reads out instructions from DNA controlling whether it…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/one-or-two-way-transcription-depends-on-gene-loops

Page 6 / 15

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 15
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search